Biomimetic Polyelectrolyte Complexes as Delivery Systems for Phytic Acid.
- 1Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
Abstract
In this study, different chitosan-alginate polyelectrolyte complexes (PECs) were investigated as a biomimetic delivery system for phytic acid (PA), a natural antioxidant with potential anticancer activity. Physicochemical characterization, including ATR-FTIR, SEM/EDX, swelling analysis, and PA release profile, demonstrated that the polymer ratio strongly influenced film morphology, stability, and PA binding. Crosslinking generally produced smoother, more compact surfaces and resulted in reduced swelling capability, particularly in alginate-rich systems. PA release in normal saline varied significantly across formulations, with the 5:1 and 1:2 ratios releasing the highest amounts after seven days as a result of higher PA content. The stability tests exhibited strong ratio-dependent degradation, with the 1:1 films remaining the most stable across all tested media. Chitosan-rich films showed moderate mass loss (up to ~25%), whereas alginate-rich films, such as the 1:5 films, disintegrated due to excessive swelling and possibly weak interactions between polymer chains. PA-crosslinked samples exhibited similar trends; alginate-rich films lost up to 60-65% of their mass, while chitosan-rich samples demonstrated that a higher chitosan content produces more stable complexes, indicating a preferable interaction between PA and chitosan. Cytotoxicity assays using MG-63 osteosarcoma and HDFa fibroblast cells revealed dose-dependent effects. While PA-free materials did not affect the viability of either cell type, extracts of PA-crosslinked films at the highest concentration reduced the viability of MG-63 and HDFa cells. Importantly, moderate concentration of PA-crosslinked film extracts affected only MG-63 cells without harming fibroblasts, potentially suggesting mild preferential activity. Overall, the results demonstrate that PA-crosslinked PEC films provide a tunable, biomimetic platform with structural, physicochemical, and biological properties that can be modulated by adjusting the polymer ratio. The combination of enhanced stability, controlled PA release, and dose-dependent cytotoxicity offers potential for further development as antitumor materials.
Related
- Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges.
- Alginate/chitosan polyelectrolyte complexes: A comparative study of the influence of the drying step on physicochemical properties
- Composition-controlled assembly of poly(amic acid) salt and polyethyleneimine into core-shell polyelectrolyte complexes
- Exploring the photodynamical landscape of biomimetic lumichrome–ephedrine-class amine complexes across femtosecond to millisecond regimes
- Targeted delivery of celastrol and siRNA via macrophage biomimetic nanoparticles for doxorubicin-induced cardiomyopathy therapy
BibTeX
@article{malbasa2026biomimetic,
title = {{Biomimetic Polyelectrolyte Complexes as Delivery Systems for Phytic Acid.}},
author = {Zoran Malbaša and Mihael Žvab and Anamarija Rogina},
journal = {Biomimetics (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/biomimetics11100718},
url = {https://europepmc.org/article/MED/42930270},
note = {CC BY},
}
RIS
TY - JOUR
TI - Biomimetic Polyelectrolyte Complexes as Delivery Systems for Phytic Acid.
AU - Zoran Malbaša
AU - Mihael Žvab
AU - Anamarija Rogina
PY - 2026
DA - 2026/10/09
JO - Biomimetics (Basel, Switzerland)
DO - 10.3390/biomimetics11100718
UR - https://europepmc.org/article/MED/42930270
AB - In this study, different chitosan-alginate polyelectrolyte complexes (PECs) were investigated as a biomimetic delivery system for phytic acid (PA), a natural antioxidant with potential anticancer activity. Physicochemical characterization, including ATR-FTIR, SEM/EDX, swelling analysis, and PA release profile, demonstrated that the polymer ratio strongly influenced film morphology, stability, and PA binding. Crosslinking generally produced smoother, more compact surfaces and resulted in reduced swelling capability, particularly in alginate-rich systems. PA release in normal saline varied significantly across formulations, with the 5:1 and 1:2 ratios releasing the highest amounts after seven days as a result of higher PA content. The stability tests exhibited strong ratio-dependent degradation, with the 1:1 films remaining the most stable across all tested media. Chitosan-rich films showed moderate mass loss (up to ~25%), whereas alginate-rich films, such as the 1:5 films, disintegrated due to excessive swelling and possibly weak interactions between polymer chains. PA-crosslinked samples exhibited similar trends; alginate-rich films lost up to 60-65% of their mass, while chitosan-rich samples demonstrated that a higher chitosan content produces more stable complexes, indicating a preferable interaction between PA and chitosan. Cytotoxicity assays using MG-63 osteosarcoma and HDFa fibroblast cells revealed dose-dependent effects. While PA-free materials did not affect the viability of either cell type, extracts of PA-crosslinked films at the highest concentration reduced the viability of MG-63 and HDFa cells. Importantly, moderate concentration of PA-crosslinked film extracts affected only MG-63 cells without harming fibroblasts, potentially suggesting mild preferential activity. Overall, the results demonstrate that PA-crosslinked PEC films provide a tunable, biomimetic platform with structural, physicochemical, and biological properties that can be modulated by adjusting the polymer ratio. The combination of enhanced stability, controlled PA release, and dose-dependent cytotoxicity offers potential for further development as antitumor materials.
SN - 2313-7673
ER -